Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study Athersys to continue to provide close support to ...

Bellani G, Laffey JG, Pham T, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study. Am J Respir Crit Care Med 2017;195:67-77.

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, can present with a spectrum of clinical manifestations – ranging from mild infection of the upper respiratory tract to severe ...

The reason behind acute respiratory distress syndrome development in some patients suffering with severe respiratory illness and not others is unknown, but recent research suggests a possible ...

Acute respiratory distress syndrome, also known as ARDS, is a common killer among critically ill patients hospitalized with COVID-19. But even if they survive, it’s a long road to recovery.

“Acute respiratory distress syndrome is triggered by a variety of etiologic agents. Currently, there are no FDA-approved drugs to treat ARDS because of which the mortality rate is close to 40% ...

Charles Maldarelli. Respiratory distress when a lung surfactant loses one of its two hydrophobic tails. Proceedings of the National Academy of Sciences, 2024; 121 (10) DOI: 10.1073/pnas.2320426121 ...

Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. JAMA Network Open, 2021; 4 (12): e2140568 DOI: 10.1001/jamanetworkopen.2021.40568 ...

Severe acute respiratory syndrome (SARS) is a respiratory disease first reported in China in 2002. A coronavirus caused the SARS outbreak, which starts with body aches and mild respiratory symptoms.